Separation of Plasminogen Activators from Human Plasma and a Comparison with Activators from Human Uterine Tissue and Urine

Summary

Normal human plasma contains acid-stable as well as labile plasminogen activators. The activity of activators in plasma euglobulins was inhibited by EACA in an uniform pattern, similar to that obtained with the major activators in human uterine tissue or with the purified porcine tissue activator, but different from the patterns obtained with plasmin or with urokinase.

Gel filtration at high ionic strength separated activators corresponding to particle sizes of 60,000 dalton and about 10,000 dalton, corresponding to two activators similarly obtained from human tissue. The 60,000 dalton activator was precipitated in the euglobulin fraction. Its concentration increased in plasma after exercise. The 10,000 dalton activator was found mainly in the supernatant. Gel filtration in 0.15 M solutions yielded activators in fractions of molecular sizes of 100-140,000 dalton and 200,000 dalton or larger.

The activity of normal and exercise euglobulins was inhibited by antiserum to a plasminogen activator prepared from porcine tissue, but it was not inhibited by antiserum to urokinase. Plasminogen activators in human plasma euglobulins resembled immunochemi- cally the activators in human uterine tissue.

• References

• 1 Aoki N, Von Kaulla KN. 1971; The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. American Journal of Clinical Pathology 55: 171
• 2 Astrup T, Brakman P, Kok P, Thorsen S. 1973. The accurate assay of fibrinolytic activity of blood. Fourth Congress on Thrombosis and Haemostasis. Vienna, Austria: 19.06.1973. Abstract no 428
• 3 Astrup T, Rosa AT. 1974; A plasminogen proactivator activator system in human blood effective in absence of Hageman factor. Thrombosis Research 4: 609
• 4 Auerswald W, Binder B, Doleschel W. 1971; ”Angiokinase”-molecular weights of proteins representing a perivascular plasminogen activator. Thrombosis et Diathesis Haemorrhagica 26: 411
• 5 Biggs R, Macfarlane RG, Pilling J. 1947; Observations of fibrinolysis. Lancet 1: 402
• 6 Brakman P. 1967. Fibrinolysis. A standardized fibrin plate method and a fibrinolytic assay of plasminogen. Scheltema&Holkema N. V.; Amsterdam:
• 7 Cole E, Bachmann F, Marchant L. 1978. Plasminogen activators from porcine tissues: Enzymatic and immunological properties. In: Davidson JF, Rowan RM, Samana MM, Desnoyers PC. (eds.) Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 3.. Raven Press; New York: p 99
• 8 Fearnley GR, Balmforth G, Fearnley E. 1957; Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clinical Science 16: 645
• 9 Hamberg U. 1966; Separation of plasminogen activator from normal and lytic human plasma. Life Sciences 5: 731
• 10 Holemans R. 1967 Differentiation of blood and tissue activator of plasminogen. Federation Proceedings. 26. Abstract
• 11 Kluft C. 1978. Levels of plasminogen activators in human plasma: New methods to study the intrinsic and extrinsic activators. In: Davidson JF, Rowan RM, Samana MM, Desnoyers PC. (eds.) Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 3.. Raven Press; New York: p 141
• 12 Kok P. 1972. b Demonstration of different types of plasminogen activators in human tissue and a comparison with activators in urine and blood. Third Congress on Thrombosis. Washington, D. C.: 22.08.1972. Abstract p 300
• 13 KOK P. 1978; Separation of plasminogen activators from human uterine tissue, and a comparison with activators from human urine and porcine tissue. Thrombosis and Haemostasis 41: 718
• 14 Kok P, Astrup T. 1969; a Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry 8: 19
• 15 Kok P, Astrup T. 1969; b Distinction of human tissue plasminogen activator from human urokinase with e-aminocaproic acid (EACA). Federation Proceeding 28: 441 Abstract
• 16 Kucinski CS, Fletcher AP, Sherry S. 1968; Effect of urokinase antiserum on plasminogen activators: Demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. Journal of Clinical Investigation 47: 1238
• 17 Marx R. 1955. Neuere Ergebnisse von Studien iiber Bedingtheit der Fibrinolyse in Serum in vitro. In: KOLLER Th, and MERZ WR. (ed.) Proceedings of the Conference on Thrombosis and Embolism; Basel: p 108
• 18 Müllertz S. 1953; A plasminogen activator in spontaneously active human blood. Proceedings of the Society for Experimental Biology and Medicine 82: 291
• 19 Ogston D, Bennet B, Mackie M. 1976; Properties of a partially purified preparation of a circulating plasminogen activator. Thrombosis Research 8: 215
• 20 Pugath EM F, POOLE JC F. 1969; Studies on the fibrinolytic activity of an extract from vascular endothelium. Quarterly Journal of Experimental Physiology 54: 80
• 21 Rosing DR, Brakman P, Redwood DR, Goldstein RE, Beiser G-D, Astrup T, Epstein SE. 1970; Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circulation Research 27: 171
• 22 Siew C, Celander E. 1968; Plasmin activator in the cytoplasmic granules of bovine jugular vein endothelium. Enzymologia Biologica et Clinica 9: 459